Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
Public ClinicalTrials.gov record NCT00017069. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CTI 1060: A Phase II Clinical Trial of Arsenic Trioxide and Dexamethasone as Therapy for Relapsed or Refractory Multiple Myeloma
Study identification
- NCT ID
- NCT00017069
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- CTI BioPharma
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- arsenic trioxide Drug
- dexamethasone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 120 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2001
- Primary completion
- Dec 31, 2004
- Completion
- Dec 31, 2004
- Last update posted
- Oct 4, 2020
2001 – 2005
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Clinical Research Center | Tucson | Arizona | 85712 | — |
| Highlands Oncology Group - Springdale | Springdale | Arkansas | 72764 | — |
| St. Joseph Hospital Regional Cancer Center - Orange | Orange | California | 92868-3849 | — |
| Stockton Hematology Oncology Medical Group | Stockton | California | 95204 | — |
| Rocky Mountain Cancer Centers - Midtown | Denver | Colorado | 80218 | — |
| Pasco Pinellas Cancer Center - Tarpon Springs | Tarpon Springs | Florida | 34689 | — |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | — |
| Mountain States Tumor Institute - Boise | Meridian | Idaho | 83642 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10021 | — |
| Texas Cancer Care | Fort Worth | Texas | 76104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00017069, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 4, 2020 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00017069 live on ClinicalTrials.gov.